Navigation Links
New advances in cancer research to be highlighted at University of Leicester
Date:4/21/2009

A scientist whose work is key to understanding how cancer cells divide and spread in the body is to present advances in his latest research at a public forum to be held at the University of Leicester.

Professor Andrew Fry, of the Department of Biochemistry, leads a renowned research group at the University of Leicester that is internationally consulted as a leading laboratory in the field of Molecular Cell Biology.

Many current cancer treatments act by killing all dividing cells and are not necessarily specific for the cancer cells, hence the severe side effects. One of Professor Fry's aims is to understand the molecular control of cell division and as a result identify proteins which can be targeted in specific tumours, leaving other cells unharmed.

On Tuesday April 28, Professor Fry will discuss his research and its future direction. The lecture, How Cells Control the Great Divide, in the Ken Edwards Building Lecture Theatre 1, starts at 5.30pm. It is open to the public and free.

Professor Fry said: "In my presentation, I will highlight how our research has contributed to the understanding of a key aspect of human cell biology that is cell division. This research has provided important new insights on the causes of many human diseases, including cancer, and led to the identification of a number of new targets for cancer treatment.

"An adult human being contains millions of cells that all arise following the fertilization of an egg cell by a sperm cell. Human development therefore requires cells to divide again and again to create the tissues and organs of our body. Cell division is a complex mechanical process that not only leads to the production of new cells but ensures that each one maintains the right genetic content required to sustain life. Loss of control over cell proliferation and the development of genetic and chromosomal abnormalities are classic hallmarks of cancer."

Professor Fry added that the group's research falls into three broad areas:

  • Study of a family of proteins that play a role in cell division and cilia organization which makes them attractive targets for the development of new anti-cancer drugs

  • Research on a particular structure that lies at the heart of each and every cell, called the centrosome (standing for "central body"), and how centrosome defects contribute to cancer progression

  • Examination of the cell biological basis of ciliopathy disorders, a diverse set of devastating human diseases with symptoms ranging from polycystic kidney disease to mental retardation, obesity and progressive blindness.

"Something that has helped us to establish a world-class reputation is a state-of-the-art Microscopy facility at the University of Leicester. The ability to use high resolution microscopy, to see what is actually going on in cells, is critical to research. So having this facility at Leicester allows us to compete at world level."


'/>"/>

Contact: Professor Andrew Fry
amf5@le.ac.uk
44-116-229-7069
University of Leicester
Source:Eurekalert

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
3. Major grant advances UWs clinical and translational research enterprise
4. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
5. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
6. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
7. Advances in drug screening: building a better haystack for the needles of tomorrow
8. Advances in Cancer Research, Funding Stem Cell Research, and More at Annual Cancer Congress
9. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
10. Springer adds Advances in Therapy to journals portfolio
11. NIH grant advances dentistry schools work on psychosocial stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology Business ... focus on current legislative activity and the latest regulatory concerns impacting RBMA members. ... Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head ... bold recipes for Memorial Day entertaining that are sure to satisfy your guests’ ... fresh sliced meats and cheeses featured in these refreshingly balanced recipes are packed ...
(Date:5/26/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... Agreements being discussed by President Donald Trump and the rest of the world. Donald ... up peace talks in the continuous battle between Israel and Palestine. The world’s eyes ...
(Date:5/26/2017)... ... ... “When the Stars Lead Home”: a poignant story of loss, determination, and perseverance. “When ... avid reader who lives in the Pacific Northwest with her husband, daughter, two dogs, ... She couldn’t be more grateful. , Twelve-year old Tizzy could not believe how quickly ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: the ... others. “Cactus Jack: Against All Odds” is the creation of published author, Walter ... is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane have ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017 CSSi, the global ... the clinical research industry, is proud to announce the ... The new website features both enriched content and a ... and enhances the company,s already well-established position as the ... "After many months of hard work, we ...
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, Inc. ... technology solutions to improve the clinical effectiveness and ... for the first quarter ended March 31, 2017. ... enable our customers to identify when preventive care ... before events like heart attacks or strokes occur," ...
Breaking Medicine Technology: